1Vasa M,Fichtlscherer S,Adler K.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001; 103:2885-2890.
2Soma MR,Donetti E,Parolini C,et al.HMG-CoA reductase inhibitors:in vivo effects on carotid intimal thickening in normocholesterolemic rabbits[J].Arterioscler Thromb,1993; 13:571 -578.
3Kong WJ,Wei J,Abidi P,et al.Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins[J].Nat Med,2004;10:1344 -1351.
1[1]Srauss WE, Fortin T, Hartigan P, et al. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy: outcomes of a randomized clinical trial. Circulation, 1995,92:1710-1719.
2[2]Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med, 1994,330:981-993.
3[3]King SB Ⅲ, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary bypass surgery. N Engl J Med, 1994,331:1044-1050.
4[4]Todaka T, Yokoyama C, Yanamoto H, et al. Gene transfer of human prostacylin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke, 1999,30:419-426.
5[5]Mitsunori H, Yukio T, Yasushi N, et al. Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications. Cardiovas Res, 1999,43:481-491.
6[6]Yasushi N, Keiji N, Mitsunori H. Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury. Arterioscler, Thromb Vasc Biol, 1999,19:727-733.
